Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 13

The DOI matches its Crossref record.

Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel

Capogrosso, Paolo, Dimitropolous, Kostas, Russo, Giorgio Ivan, Tharakan, Tharu, Milenkovic, Uros, Cocci, Andrea, Boeri, Luca, Gül, Murat, Bettocchi, Carlo, Carvalho, Joana, Kalkanlı, Arif, Corona, Giovanni, Hatzichristodoulou, Georgios, Jones, Hugh T., Kadioglu, Ates, Martinez-Salamanca, Juan Ignacio, Modgil, Vaibhav, Serefoglu, Ege Can, Verze, Paolo, Salonia, Andrea, Minhas, Suks, on behalf of the EAU Working Group on Sexual and Reproductive Health·2024·International Journal of Impotence Research
DOI 10.1038/s41443-022-00592-2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41443-022-00592-2

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 55

  1. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R. Priapism: Pathogenesis, epidemiology, and management. J Sex Med. 2010;7:476–500. https://doi.org/10.1111/j.1743-6109.2009.01625.x. · DOI · Paper page
  2. Salonia A, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. EAU Working Group on Male Sexual and Reproductive Health. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction. Eur Urol. 2021;80:333–57. https://doi.org/10.1016/j.eururo.2021.06.007. · DOI
  3. Muneer A, Cellek S, Ralph DJ, Minhas S. The investigation of putative agents, using an in vitro model, to prevent cavernosal smooth muscle dysfunction during low-flow priapism. BJU Int. 2008;102:988–92. https://doi.org/10.1111/j.1464-410X.2008.07778.x. · DOI
  4. Burnett AL, Sharlip ID. Standard operating procedures for priapism. J Sex Med. 2013;10:180–94. https://doi.org/10.1111/j.1743-6109.2012.02707.x. · DOI
  5. Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:1–173. https://doi.org/10.3310/hta7270. · DOI · Paper page
  6. Bansal AR, Godara R, Garg P. Cold saline enema in priapism—a useful tool for underprivileged. Trop Doct. 2004;34:227–8. https://doi.org/10.1177/004947550403400414. · DOI
  7. Bardin ED, Krieger JN. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. Int Urol Nephrol. 1990;22:147–52. https://doi.org/10.1007/BF02549833. · DOI
  8. Jiang P, Christakos A, Fam M, Sadeghi-Nejad H. Prophylactic phenylephrine for iatrogenic priapism: a pilot study with Peyronie’s patients. Korean J Urol. 2014;55:665–9. https://doi.org/10.4111/kju.2014.55.10.665. · DOI
  9. Keskin D, Cal C, Delibas M, özyurt C, Günaydin G, Nazli O, et al. Intracavernosal adrenalin injection in priapism. Int J Impot Res. 2000;12:312–4. https://doi.org/10.1038/sj.ijir.3900539. · DOI
  10. Khurana P, Bansal AR, Kamal H, Malik V. Role of cold saline enema in management of priapism. Indian J Urol. 2002;18:146–7. · DOI
  11. Kulmala R. Treatment of priapism: primary results and complications in 207 patients. Ann Chir Gynaecol. 1994;83:309–14.
  12. Kumar M, Garg G, Sharma A, Pandey S, Singh M, Sankhwar SN. Comparison of outcomes in malignant vs. non-malignant ischemic priapism: 12-year experience from a tertiary center. Turkish J Urol. 2019;45:340–4. https://doi.org/10.5152/tud.2019.75044. · DOI
  13. Larocque MA, Cosgrove MD. Priapism: a review of 46 cases. J Urol. 1974;112:770–3. https://doi.org/10.1016/s0022-5347(17)59848-1. · DOI
  14. Martínez Portillo F, Hoang-Boehm J, Weiss J, Alken P, Jünemann K. Methylene blue as a successful treatment alternative for pharmacologically induced priapism. Eur Urol. 2001;39:20–3. https://doi.org/10.1159/000052407. · DOI
  15. Molina L, Bejany D, Lynne CM, Politano VA. Diluted epinephrine solution for the treatment of priapism. J Urol. 1989;141:1127–8. https://doi.org/10.1016/s0022-5347(17)41189-x. · DOI
  16. Moloney PJ, Elliott GB, Johnson HW. Experiences with priapism. J Urol. 1975;114:72–6. https://doi.org/10.1016/s0022-5347(17)66946-5. · DOI
  17. deHoll JD, Shin PA, Angle JF, Steers WD. Alternative approaches to the management of priapism. Int J Impot Res. 1998;10:11–4. https://doi.org/10.1038/sj.ijir.3900308. · DOI
  18. Muruve N, Hosking DH. Intracorporeal phenylephrine in the treatment of priapism. J Urol. 1996;155:141–3. · DOI
  19. Pantaleo-Gandais M, Chalbaud R, Chacon O, Plaza N. Priapism: evaluation and treatment. Urology. 1984;24:345–6. https://doi.org/10.1016/0090-4295(84)90207-3. · DOI
  20. Passavanti G, Bragaglia A, Paolini R. From methylene blue (methylthionine chloride) to Al-Ghorab procedure: the therapy of priapism (our experience). Arch Ital Di Urol Androl Organo Uff [Di] Soc Ital Di Ecogr Urol e Nefrol. 2009;81:242–4.
  21. Ridyard DG, Phillips EA, Vincent W, Munarriz R. Use of high-dose phenylephrine in the treatment of ischemic priapism: five-year experience at a single institution. J Sex Med. 2016;13:1704–7. https://doi.org/10.1016/j.jsxm.2016.09.010. · DOI
  22. Saffon Cuartas JP, Sandoval-Salinas C, Martínez JM, Corredor HA. Treatment of priapism secondary to drugs for erectile dysfunction. Adv Urol. 2019;2019:6214921 https://doi.org/10.1155/2019/6214921. · DOI
  23. Serrate RG, Prats J, Regué R, Rius G. The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erections. Int Urol Nephrol. 1992;24:389–92. https://doi.org/10.1007/BF02550631. · DOI
  24. Soler J-M, Previnaire J-G, Mieusset R, Plante P. Oral midodrine for prostaglandin e1 induced priapism in spinal cord injured patients. J Urol. 2009;182:1096–100. https://doi.org/10.1016/j.juro.2009.05.009. · DOI
  25. Sönmez MG, Kara C, Karaibrahimoğlu A, Sönmez LÖ, Göğer YE, Balasar M, et al. Ischemic priapism: can eosinophil count and platelet functions be positive predictive factors in etiopathogenesis. Can Urol Assoc J = J l’Association Des Urol Du Can. 2017;11:E297–301. https://doi.org/10.5489/cuaj.4263. · DOI
  26. Stief CG, Gall H, Scherb W, Bähren W. Mid-term results of autoinjection therapy for erectile dysfunction. Urology. 1988;31:483–5. https://doi.org/10.1016/0090-4295(88)90212-9. · DOI
  27. Török A, Jilling A, Götz F. Induced priapism and its management. Int Urol Nephrol. 1991;23:191–4. https://doi.org/10.1007/BF02549718. · DOI
  28. Dittrich A, Albrecht K, Bar-Moshe O, Vandendris M. Treatment of pharmacological priapism with phenylephrine. J Urol. 1991;146:323–4. https://doi.org/10.1016/s0022-5347(17)37781-9. · DOI
  29. van Driel MF, Mooibroek JJ, Mensink HJ. Treatment of priapism by injection of adrenaline into the corpora cavernosa penis. Scand J Urol Nephrol. 1991;25:251–4. https://doi.org/10.3109/00365599109024554. · DOI
  30. Vorobets D, Banyra O, Stroy A, Shulyak A. Our experience in the treatment of priapism. Cent Eur. J Urol. 2011;64:80–3. https://doi.org/10.5173/ceju.2011.02.art6. · DOI
  31. Watters GR, Keogh EJ, Carati CJ, Earle CM, Wisniewski ZS, Tulloch AG, et al. Prolonged erections following intracorporeal injection of medications to overcome impotence. Br J Urol. 1988;62:173–5. https://doi.org/10.1111/j.1464-410x.1988.tb04301.x. · DOI
  32. Ugwumba FO, Ekwedigwe HC, Echetabu KN, Okoh AD, Nnabugwu I, Ugwuidu ES. Ischemic priapism in South-East Nigeria: Presentation, management challenges, and aftermath issues. Niger J Clin Pr. 2016;19:207–11. https://doi.org/10.4103/1119-3077.175968. · DOI
  33. Zhao H, Berdahl C, Bresee C, Moradzadeh A, Houman J, Kim H, et al. Priapism from Recreational Intracavernosal Injections in a High-Risk Metropolitan Community. J Sex Med. 2019;16:1650–4. https://doi.org/10.1016/j.jsxm.2019.07.024. · DOI
  34. Zhao H, Dallas K, Masterson J, Lo E, Houman J, Berdahl C, et al. Risk factors for surgical shunting in a large cohort with ischemic priapism. J Sex Med. 2020;17:2472–7. https://doi.org/10.1016/j.jsxm.2020.09.007. · DOI
  35. Masterson JM, Zhao H, Choi E, Kim HH, Anger JT. Characteristics and long term follow up of men who suffer ischemic priapism secondary to recreational use of intracavernosal injectable medications. Urology. 2021:1–6. https://doi.org/10.1016/j.urology.2021.06.036. · DOI
  36. Dutta R, Matz EL, Overholt TL, Anderson WB, Deebel NA, Cowper M, et al. Patient education is associated with reduced delay to presentation for management of ischemic priapism: a retrospective review of 123 men. J Sex Med. 2021;18:385–90. https://doi.org/10.1016/j.jsxm.2020.11.017. · DOI
  37. Palka J, DuComb W, Begun E, Soto-Aviles O. Factors associated with corporoglandular shunting for patients with first-time ischemic priapism. Urology. 2021;154:191–5. https://doi.org/10.1016/j.urology.2021.03.030. · DOI
  38. Patel PM, Slovacek H, Pahouja G, Patel HD, Cao D, Emerson J, et al. Socioeconomic disparities and risk factors in patients presenting with ischemic priapism: a multi-institutional study. Urology 2021:1–6. https://doi.org/10.1016/j.urology.2021.03.063. · DOI
  39. El-Bahnasawy MS, Dawood A, Farouk A. Low-flow priapism: risk factors for erectile dysfunction. BJU Int. 2002;89:285–90. https://doi.org/10.1046/j.1464-4096.2001.01510.x. · DOI
  40. FARRER JF, GOODWIN WE. Treatment of priapism: comparison of methods in fifteen cases. J Urol. 1961;86:768–75. https://doi.org/10.1016/s0022-5347(17)65259-5. · DOI
  41. Forsberg L, Hederström E, Olsson AM. Severe arterial insufficiency in impotence confirmed with an improved angiographic technique: the impact of smoking and some other etiologic factors. Eur Urol. 1989;16:357–60. https://doi.org/10.1159/000471616. · DOI
  42. Gordon SA, Stage KH, Tansey KE, Lotan Y. Conservative management of priapism in acute spinal cord injury. Urology. 2005;65:1195–7. https://doi.org/10.1016/j.urology.2004.12.036. · DOI
  43. Grace DA, Winter CC. Priapism: an appraisal of management of twenty-three patients. J Urol. 1968;99:301–10. https://doi.org/10.1016/s0022-5347(17)62697-1. · DOI
  44. Hübler J, Szántó A, Könyves K. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Int Urol Nephrol. 2003;35:519–21. https://doi.org/10.1023/b:urol.0000025617.97048.ae. · DOI
  45. Ateyah A, El-Nashar AR, Zohdy W, Arafa M, El-Den HS. Intracavernosal irrigation by cold saline as a simple method of treating latrogenic prolonged erection. J Sex Med. 2005;2:248–53. https://doi.org/10.1111/j.1743-6109.2005.20235.x. · DOI
  46. Habous M, Elkhouly M, Abdelwahab O, Farag M, Madbouly K, Altuwaijri T, et al. Noninvasive treatments for iatrogenic priapism: Do they really work? A prospective multicenter study. Urol Ann. 2016;8:193–6. https://doi.org/10.4103/0974-7796.176874. · DOI
  47. Pal DK, Biswal DK, Ghosh B. Outcome and erectile function following treatment of priapism: an institutional experience. Urol Ann. 2016;8:46–50. https://doi.org/10.4103/0974-7796.165717. · DOI
  48. Govier FE, Jonsson E, Kramer-Levien D. Oral terbutaline for the treatment of priapism. J Urol. 1994;151:878–9. https://doi.org/10.1016/s0022-5347(17)35111-x. · DOI
  49. Lowe FC, Jarow JP. Placebo-controlled study of oral terbutaline and pseudoephedrine in management of prostaglandin E1-induced prolonged erections. Urology. 1993;42:51–4. https://doi.org/10.1016/0090-4295(93)90338-b. · DOI
  50. Priyadarshi S. Oral terbutaline in the management of pharmacologically induced prolonged erection. Int J Impot Res. 2004;16:424–6. https://doi.org/10.1038/sj.ijir.3901180. · DOI
  51. Ramstein JJ, Lee A, Cohen AJ, Mmonu NA, Rios N, Enriquez A, et al. Clinical outcomes of periprocedural antithrombotic therapy in ischemic priapism management. J Sex Med. 2020;17:2260–6. https://doi.org/10.1016/j.jsxm.2020.07.013. · DOI
  52. Bansal AR, Godara R, Garg P. Cold saline enema in priapism - a useful tool for underprivileged. Trop Doct. 2004;34:227–8. https://doi.org/10.1177/004947550403400414. · DOI
  53. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JPW, Lue TF, et al. American Urological Association guideline on the management of priapism. J Urol. 2003;170:1318–24. https://doi.org/10.1097/01.ju.0000087608.07371.ca. · DOI · Paper page
  54. Wen CC, Munarriz R, McAuley I, Goldstein I, Traish A, Kim N. Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. J Sex Med. 2006;3:918–22. https://doi.org/10.1111/j.1743-6109.2005.00140.x. · DOI
  55. Bodner DR, Lindan R, Leffler E, Kursh ED, Resnick MI. The application of intracavernous injection of vasoactive medications for erection in men with spinal cord injury. J Urol. 1987;138:310–1. https://doi.org/10.1016/s0022-5347(17)43130-2. · DOI

Cited by

See all 13

Metadata

Authors
Capogrosso, P., Dimitropolous, K., Russo, G. I., Tharakan, T., Milenkovic, U., Cocci, A., Boeri, L., Gül, M., Bettocchi, C., Carvalho, J., Kalkanlı, A., Corona, G., Hatzichristodoulou, G., Jones, H. T., Kadioglu, A., Martinez-Salamanca, J. I., Modgil, V., Serefoglu, E. C., Verze, P., Salonia, A., Minhas, S., & on behalf of the EAU Working Group on Sexual and Reproductive Health
Venue
International Journal of Impotence Research
Publisher
Springer Science and Business Media LLC
Published
2022-08-22
Volume
36
Issue
1
Pages
6-19
ISSN
  • 0955-9930
  • 1476-5489
DOI
10.1038/s41443-022-00592-2
Cited by
13
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel. https://app.cochat.ai/papers/10.1038/s41443-022-00592-2
The paper
Capogrosso, P., Dimitropolous, K., Russo, G. I., Tharakan, T., Milenkovic, U., Cocci, A., Boeri, L., Gül, M., Bettocchi, C., Carvalho, J., Kalkanlı, A., Corona, G., Hatzichristodoulou, G., Jones, H. T., Kadioglu, A., Martinez-Salamanca, J. I., Modgil, V., Serefoglu, E. C., Verze, P., . . . on behalf of the EAU Working Group on Sexual and Reproductive Health. (2024). Conservative and medical treatments of non-sickle cell disease-related ischemic priapism: a systematic review by the EAU Sexual and Reproductive Health Panel. International Journal of Impotence Research. https://doi.org/10.1038/s41443-022-00592-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.